Target intelligence / Profile preview

Voltage-dependent calcium channel subunit beta (VDCC-beta) (VDCC-beta)

Target
VDCC-beta
Molecular classification
Ion channel, Voltage-gated ion channel, Calcium channel
01

Overview

Voltage-dependent calcium channels (VDCCs) in platyhelminths are essential membrane proteins that mediate the influx of calcium ions in response to membrane depolarization, playing a pivotal role in neuromuscular function and tegumental stability (Greenberg, 2005). These channels are composed of a pore-forming alpha-1 subunit and auxiliary subunits, including a parasite-specific beta subunit that is structurally distinct from those found in vertebrate hosts (Kohn et al., 2001). This divergence is characterized by the absence of certain conserved motifs and the presence of unique sequences that alter the channel's biophysical properties and pharmacological sensitivity (Park et al., 2002). The VDCC complex is the primary molecular target of praziquantel, the leading treatment for schistosomiasis and other trematode infections. Praziquantel acts as an allosteric modulator that triggers a rapid and sustained calcium influx, resulting in the spastic paralysis of the worm and the disruption of its protective outer layer (tegument) (Park et al., 2021). This mechanism effectively allows the host's immune system to recognize and eliminate the parasite, though the specific requirement of the beta subunit for drug efficacy remains a key area of anthelmintic research.

Other names
Platyhelminth voltage-gated calcium channelSchistosome calcium channel beta subunitSmbetaCav beta subunitPraziquantel target
02

Mechanism of action

Praziquantel acts as an allosteric activator of the voltage-gated calcium channel complex, requiring the parasite-specific beta subunit for its unique pharmacological profile, leading to massive calcium influx and parasite paralysis (Park et al., 2021).

03

Biological functions

Calcium signalingMuscle contractionNeuromuscular coordinationTegumental integrity maintenance
04

Disease associations

InfectionSchistosomiasisCysticercosisTrematodiasis
05

Safety considerations

Potential for drug resistanceLack of efficacy against juvenile parasites (schistosomula)Host inflammatory reactions to dead or dying parasites in tissues
06

Interacting drugs

Praziquantel
07

Biomarkers

Parasite egg reduction rate (ERR)Circulating anodic antigen (CAA) levelsCirculating cathodic antigen (CCA) levels

Beyond the preview

Go deeper on Voltage-dependent calcium channel subunit beta (VDCC-beta) (VDCC-beta).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-dependent calcium channel subunit beta (VDCC-beta) (VDCC-beta).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call